August 5, 2025 - 07:57

Figure Technology has filed draft paperwork for an initial public offering (IPO) with the Securities and Exchange Commission (SEC), marking a significant move in the evolving landscape of digital assets. This development positions Figure alongside other notable firms in the sector, such as Grayscale, Bullish, and BitGo, all of which are also pursuing IPOs.
As the digital asset industry continues to gain traction, companies are increasingly looking to capitalize on public market opportunities. Figure Technology, known for its innovative solutions in the blockchain space, aims to leverage this momentum to enhance its visibility and expand its operations. The filing reflects a broader trend of traditional financial institutions and tech companies seeking to establish a foothold in the burgeoning digital economy.
Investors and market watchers are keenly observing these developments, as the success of these IPOs could pave the way for more firms in the digital asset realm to follow suit, potentially reshaping the financial landscape.
August 4, 2026 - 19:37
When Tech Outpaces the Pentagon's Buying PowerThe gap between how fast private industry develops new technology and how quickly the government can buy it is getting wider, and that mismatch is creating real problems for national defense....
August 4, 2026 - 03:37
Idaho, Utah among finalists for nuclear waste, nuclear technology sitesFederal officials have narrowed the list of potential locations for a major nuclear waste management and technology complex, and both Idaho and Utah are still in the running. The chosen campuses...
August 3, 2026 - 01:31
Credo Technology Stock (CRDO) Opinions on AI Infrastructure ExpansionRecent discussions among investors and industry watchers have shifted focus to Credo Technology and its role in the rapidly expanding AI data center market. The conversation centers on the...
August 2, 2026 - 00:47
FDA weighs a new kind of flu shot based on technology RFK Jr. has questionedThe Food and Drug Administration is nearing a decision on a new type of influenza vaccine developed by Moderna, one that uses the same messenger RNA platform behind the company`s COVID-19 shots. If...